Latest News:

Democratic National Convention: What to watch for at Biden’s nomination party -

Monday, August 17, 2020

Republicans dismiss Trump proposal to delay election -

Thursday, July 30, 2020

Obama calls filibuster ‘Jim Crow relic,’ backs new Voting Rights Act bill -

Thursday, July 30, 2020

Donald Trump suggests delay to 2020 US presidential election -

Thursday, July 30, 2020

US teenager wins $3m playing computer game Fortnite -

Sunday, July 28, 2019

Dozens of mourners ‘killed by Boko Haram’ at a funeral in north Nigeria -

Sunday, July 28, 2019

Dan Coats, Trump’s top intel official, to depart White House -

Sunday, July 28, 2019

Donald Trump’s power dynamic with Nancy Pelosi will be on full display at the State of the Union -

Tuesday, February 5, 2019

Pennsylvania poll: Clinton up by 9 points – QuestCinq.com -

Thursday, July 28, 2016

Your Ports!! – QuestCinq.com -

Wednesday, July 13, 2016

In shadow of Brexit, NATO considers Russian deterrence – QuestCinq.com -

Wednesday, July 6, 2016

Italy vs Spain,England vs Iceland; Boston Red Sox vs Tampa Bay Rays – QuestCinq.com -

Monday, June 27, 2016

Foreign diplomats voicing alarm to U.S. officials about Trump – QuestCinq.com -

Monday, March 7, 2016

Trump grants press credentials to ‘pro-white’ radio show host – QuestCinq.com -

Wednesday, March 2, 2016

Supreme Court rejects Arizona sheriff’s appeal on immigration – QuestCinq.com -

Tuesday, January 19, 2016

Hawking: Humans at risk of lethal ‘own goal’ – QuestCinq.com -

Tuesday, January 19, 2016

ObamaCare supporters see wall of resistance cracking in South – QuestCinq.com -

Saturday, November 21, 2015

Attaque revendiquée par l’EI au Bangladesh: un mort et 80 blessés -

Saturday, October 24, 2015

Russia says wants Syria elections, ready to help Free Syrian Army -

Saturday, October 24, 2015

Hillary Clinton calls Republican’s impeachment vow ‘pathetic’ -

Saturday, October 24, 2015

Vaccine ‘clears HIV-like virus’ in monkeys

–A vaccine for the monkey equivalent of HIV appears to eradicate the virus, a study suggests.

Research published in the journal Nature has shown that vaccinated monkeys can clear Simian Immunodeficiency Virus (SIV) infection from their bodies.

It was effective in nine of the 16 monkeys that were inoculated.

The US scientists say they now want to use a similar approach to test a vaccine for HIV in humans.

Prof Louis Picker, from the Vaccine and Gene Therapy Institute at Oregon Health and Science University, said: “It’s always tough to claim eradication – there could always be a cell which we didn’t analyse that has the virus in it. But for the most part, with very stringent criteria… there was no virus left in the body of these monkeys.”

Search and destroy

The research team looked at an aggressive form of virus called SIVmac239, which is up to 100 times more deadly than HIV.

Infected monkeys usually die within two years, but in some inoculated primates the virus did not take hold.

The vaccine is based on another virus called cytomegalovirus (CMV), which belongs to the herpes family.

It used the infectious power of CMV to sweep throughout the body. But instead of causing disease, it has been modified to spur the immune system into action to fight off the SIV molecules.

“It maintains an armed force, that patrols all the tissues of the body, all the time, indefinitely,” explained Prof Picker.

The researchers gave rhesus macaque monkeys the vaccine, and then exposed them to SIV.

They found that at first the infection began to establish and spread. But then the monkeys’ bodies started to respond, searching out and destroying all signs of the virus.

Of the monkeys that successfully responded to the vaccine, they were still clear of infection between one-and-a-half and three years later.

Prof Picker said his team was still trying to work out why the vaccination worked in only about half of the monkeys.

“It could be the fact that SIV is so pathogenic that this is the best you are ever going to get.

“There is a battle going on, and half the time the vaccine wins and half the time it doesn’t,” he said.

Human trials

The researchers are now testing the vaccine to see if it can be used after SIV exposure to treat and potentially cure infected monkeys.

They also want to see if the technique could work in humans.

Prof Picker said: “In order to make a human version we have to make sure it is absolutely safe.

A rhesus macaque monkey The researchers now want to move from monkeys to test the vaccine in humans

“We have now engineered a CMV virus which generates the same immune response but has been attenuated [modified to lose its virulence] to the point where we think it is unequivocally safe.”

This would first have to pass through the regulatory authorities, but if it does, he said he hoped to start the first clinical trials in humans in the next two years.

Commenting on the research, Dr Andrew Freedman, from Cardiff University School of Medicine, said: “This suggests that prophylactic vaccines – vaccines designed to prevent infection – using CMV vectors may be a promising approach for HIV.

“While they may not prevent the initial infection, they might lead to subsequent clearance, rather than the establishment of chronic infection.”

By Rebecca Morelle

Source: BBC

Comments are closed.

Yahoo! Status Checker by Techya